Terms: = Uterine cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Treatment
21 results:
1. Disparities in geospatial patterns of cancer care within urban counties and structural inequities in access to oncology care.
McGee-Avila JK; Richmond J; Henry KA; Stroup AM; Tsui J
Health Serv Res; 2023 Aug; 58 Suppl 2(Suppl 2):152-164. PubMed ID: 37208901
[TBL] [Abstract] [Full Text] [Related]
2. Pertuzumab Plus Trastuzumab in Patients With Endometrial cancer With
Ahn ER; Rothe M; Mangat PK; Garrett-Mayer E; Ali-Ahmad HM; Chan J; Maitland ML; Patel SR; Reese Z; Balmanoukian AS; Drescher CW; Li R; Tsimberidou AM; Leath CA; O'Lone R; Grantham GN; Halabi S; Schilsky RL
JCO Precis Oncol; 2023 Apr; 7():e2200609. PubMed ID: 37027810
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.
Liu C; Zhang M; Yan X; Ni Y; Gong Y; Wang C; Zhang X; Wan L; Yang H; Ge C; Li Y; Zou W; Huang R; Li X; Sun B; Liu B; Yue J; Yu J
Sci Adv; 2023 Jan; 9(4):eadd8977. PubMed ID: 36706185
[TBL] [Abstract] [Full Text] [Related]
4. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical cancer.
Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
[TBL] [Abstract] [Full Text] [Related]
5. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells.
Wang C; Zeng J; Li LJ; Xue M; He SL
Cell Death Dis; 2021 Nov; 12(11):1055. PubMed ID: 34743185
[TBL] [Abstract] [Full Text] [Related]
6. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
[TBL] [Abstract] [Full Text] [Related]
7. Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis.
Batman S; Bohn J; Weisenberger MW; Hersh A; Bruegl A; Caughey A; Winter W
Gynecol Oncol; 2021 Jan; 160(1):214-218. PubMed ID: 33393480
[TBL] [Abstract] [Full Text] [Related]
8. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract] [Full Text] [Related]
9. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
[TBL] [Abstract] [Full Text] [Related]
10. Response to erbb3-Directed Targeted Therapy in
Drilon A; Somwar R; Mangatt BP; Edgren H; Desmeules P; Ruusulehto A; Smith RS; Delasos L; Vojnic M; Plodkowski AJ; Sabari J; Ng K; Montecalvo J; Chang J; Tai H; Lockwood WW; Martinez V; Riely GJ; Rudin CM; Kris MG; Arcila ME; Matheny C; Benayed R; Rekhtman N; Ladanyi M; Ganji G
Cancer Discov; 2018 Jun; 8(6):686-695. PubMed ID: 29610121
[No Abstract] [Full Text] [Related]
11. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
12. Prevalence of Abnormal Papanicolaou Test Results and Related Factors among Women Living in Zanjan, Iran.
Maleki A; Ahmadnia E; Avazeh A; Mazloomzadeh S; Molaei B; Jalilvand A
Asian Pac J Cancer Prev; 2015; 16(16):6935-9. PubMed ID: 26514471
[TBL] [Abstract] [Full Text] [Related]
13. Feasibility, acceptability, and effectiveness of visual inspection of the cervix with acetic acid and cryotherapy for dysplasia in Nigeria.
Adefuye PO; Dada OA; Adefuye BO; Shorunmu TO; Akinyemi BO; Idowu-Ajiboye BO
Int J Gynaecol Obstet; 2015 Apr; 129(1):62-6. PubMed ID: 25593107
[TBL] [Abstract] [Full Text] [Related]
14. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract] [Full Text] [Related]
15. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE CERVICAL cancer IN KENYA.
Gichangi P; Gathece L; Estambale B; Temmerman M
East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
[TBL] [Abstract] [Full Text] [Related]
16. Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies.
Faratian D; Zweemer AJ; Nagumo Y; Sims AH; Muir M; Dodds M; Mullen P; Um I; Kay C; Hasmann M; Harrison DJ; Langdon SP
Clin Cancer Res; 2011 Jul; 17(13):4451-61. PubMed ID: 21571868
[TBL] [Abstract] [Full Text] [Related]
17. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid.
Nessa A; Hussain MA; Rahman JN; Rashid MH; Muwonge R; Sankaranarayanan R
Int J Gynaecol Obstet; 2010 Nov; 111(2):115-8. PubMed ID: 20674919
[TBL] [Abstract] [Full Text] [Related]
18. Expression of the epidermal growth factor system in endometrial cancer.
Adonakis G; Androutsopoulos G; Koumoundourou D; Liava A; Ravazoula P; Kourounis G
Eur J Gynaecol Oncol; 2008; 29(5):450-4. PubMed ID: 19051810
[TBL] [Abstract] [Full Text] [Related]
19. Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells.
Konecny GE; Venkatesan N; Yang G; Dering J; Ginther C; Finn R; Rahmeh M; Fejzo MS; Toft D; Jiang SW; Slamon DJ; Podratz KC
Br J Cancer; 2008 Mar; 98(6):1076-84. PubMed ID: 18334972
[TBL] [Abstract] [Full Text] [Related]
20. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma.
Rao PH; Arias-Pulido H; Lu XY; Harris CP; Vargas H; Zhang FF; Narayan G; Schneider A; Terry MB; Murty VV
BMC Cancer; 2004 Feb; 4():5. PubMed ID: 15018632
[TBL] [Abstract] [Full Text] [Related]
[Next]
